The Inovatzia Vision

Inovatzia Inc. is a research company centered around a suite of core inventions by Stan Petrov, an immigrant from Eastern Europe and American citizen. Inspired by Nikola Tesla, Stan has created a world where control of the stand-alone devices that make up current medical equipment, household appliances, and even footwear is accessible and customizable via a unique technology and communication network.

A managing partner in an investment firm described Stan as having a “once in a generation” type of gifting. With experience working as a senior electrician and a mechanic, a successful medical student, an experienced consumer, and a recognized inventor, Stan is well-placed to bridge the gap to invent crossover devices—the ultimate tools where the consumer is in charge and the producer is empowered to respond to their needs. The devices have been engineered to be both elegant and simple. Inovatzia’s motto is, “It fits you.” Every invention yields a product designed to fit the consumer, not the other way around.

R&D

Inovatzia, Inc.’s inventor is a continuous source of innovative ideas in a number of focused areas. All are connected by the use of Inovatzia’s novel core technology. An Executive Board decides whether, when and how each specific product is developed and marketed.

Currently, Inovatzia’s core technology can be integrated into:

  • Re-designed home appliances and cooling systems;
  • Medical devices, controllers, and peripheral equipment;
  • Electrical components and integrated circuits;
  • Clothing and intelligent shoe gear that actively fits you;
  • IAS, a totally new experience in software that simplifies the user interface
  • Automotive products, which will result in a totally new driving experience.

Inovatzia incorporated in June of 2013. It then created prototypes and built a considerable intellectual property portfolio by the end of the year. As a result, a complete working model of the Cryo will be introduced to the public in June 2014. Currently, a working model of the Intelligent Bottle is also being produced; that IP will be marketed in the fall of 2104. The ultimate goal is to shape Inovatzia into an umbrella company for a diversity of IP and products—channeling the tsunami of invention into many pipelines of profit.

The Matrix



THE PROBLEM

The ability to walk is vital for most animals and usually does not seem to result in problems. However, humans stand up to walk, causing difficulties unique to our species. Forces created by simply standing or walking give rise to large amounts of stress, which can translate into tremendous amounts of damage, not just to the feet, but also to the ankles, legs, hips and even back.

But, this does not always occur, as is evidenced by the large numbers of foot surgeries, orthotic devices, and patients visiting podiatric and orthopedic surgeons. In fact, it has been estimated that 25% of the older population experiences foot pain on a daily basis and that 75% of the population will experience debilitating foot problems at least once in their lives. On average, a person will take 10,000 steps a day; those in the military services or in active jobs take many more, leading to increased foot-related problems. To make matters worse, changes in our environment over last few centuries, where we walk on hard and unyielding surfaces, wear “fashion” shoes, and eat more than is healthy have placed new demands on the feet.

To address these problems and to help comfort and protect the foot, various devices have been invented and modified: shoes, orthotics, and inserts. Footwear that relies on the use of springs, rubber, foam, and polymers to decrease pressure in the target areas is already on the market. Unfortunately, these materials inevitably eventually deform, possibly locking the foot in certain positions and effectively limiting the range of motion. The effect of this can be seen with new military recruits where the boots immobilize the foot, so that the extra force from routine exercises leads to a stress fracture rate of approximately 13-40% (varies by gender, race, etc).

Finally, almost 10% of Americans today struggle with diabetes, and the number is rising. This debilitating disease affects the feet in a number of ways. Ensuing neuropathy results in patients not having the sensory ability to know when standing in a particular position or walking in particular ways is causing pain, blisters, or other skin breakdown. Ulceration and even the necessity for amputation can soon follow. This peripheral neuropathy is also a common side effect of chemotherapy.

THE ANSWER

The Matrix (patent pending) will be invaluable for:
1. reducing stress fracture rates in the military and athletes;
2. decreasing ulceration and amputation in diabetics (a recent study saw a 50% reduction in the need for amputation by changes in footware alone), cancer survivors, and others with neuropathic changes in their feet, and
3. aiding the general public who often stand, walk, and run on unnatural surfaces, sometimes in shoes that are more fashionable then sensible.
Watch this space for more information.
(a recent study at the University of Gothenburg saw a 50% reduction in the need for amputation by changes in footware alone)

The Intelligent Container



THE PROBLEM

As science and medicine have added to our knowledge base, our understanding of the human body and effects of the various environmental factors on it has advanced. We are adept at manufacturing and using various substances to enhance our appearance, protect us from the environment, improve our health, and more. The market is flooded with cosmetics. In fact, it has been estimated that the average consumer applies nine products to their body per day.

Currently most of these compounds come premixed or, at most, in containers that allow one time mixing and dispensing in preset proportions. But, the human body and the environment are both dynamic, meaning that the cosmetic being dispensed is rarely, if ever, specifically tailored to the individual and their circumstances.

In the above and a myriad of other circumstances, the user does not experience the full benefits of a product simply because the mixture has not been tailored to meet their individual needs. The result is that they end up buying multiple products, which will be less effective and may provide unsatisfactory results. Moreover, this can be costly, especially in terms of the environment, when one considers that plastic cosmetic containers are a large contributor to landfill waste and leftover cosmetics can be toxic.

This is the time for development of new technologies that take into account the uniqueness of the each user as well as the real-time environmental factors, providing personalized cosmetics.

THE ENVIRONMENTAL IMPACT


According to the Euromonitor, the cosmetics industry alone produces 120.8 billion units of packaging per year. Of this, most of the post consumer plastics are not recycled and are added to landfills, pollute the oceans, harm at least 270 species of wildlife, impact the economy by reducing tourism, and may even threaten human health. Recycling is not an ideal choice because the need to clean and separate the plastics may make the product more expensive than it would be if only virgin materials were used.

It appears that Boots Chemists’ idea of refillable packing may be the best. There are negatives associated with use of refillable products: inconvenience, difficulty of use, cost, and poor product quality. However, the positives, which include less waste, less space, durable packaging, and altruism with regard to the environment appear to balance these. According to the Boots study, consumers will purchase if the packaging is exciting, amusing, surprising and satisfying.

THE ANSWER

The Intelligent bottle (patent pending) combines the advantages of being refillable, exciting, amusing, surprising and satisfying with being made to fit you. The Intelligent bottle is the packaging of the future—it fits you.

The Cryo



Cell and bioengineered skin substitute-based technologies are becoming increasingly necessary and popular. But, the technology involved in transport, storage, and use of the biomaterial has not kept pace with the biotechnical advances, consisting mostly of Styrofoam boxes and dry ice.

In comparison, the Cryo (patents pending) is a container that self-regulates to preset temperatures, interacts with its environment, provides the user with up-to-date, sharp, and sterile surgical instruments, and enables the manufacturer and medical provider to effortlessly comply with 1271 FDA requirements.

The Cryo gives the user access to all he needs literally at his fingertips. There are few that would prefer the old system once they have experienced the Cryo.

The Adaptable Medical Controller ("M")



The Adaptable Medical Controller or AMC (patent pending) is a suite of inventions that take medical equipment to a higher level by combining ergonomics, communication, versatility, and functionality, providing a higher standard and ease of care than has previously been imagined…medical devices with intelligence.

The first model of the AMC will be on sale in June, 2014. Watch this space for more information.

The Revolutionary Wire and Track-free Motherboard

Current electronics are built with permanently soldered hardware, so they must be discarded when even just one component breaks or needs to be upgraded. Inovatzia has developed a completely disruptive wire- and connection-free motherboard that allows for a vast number of components to be simultaneously interconnected, giving it a multiplicity of potential applications. This manner of integrating components allows users to upgrade or replace faulty parts without the need for special instruments or tools. Modules can be placed anywhere on the board to create the desired device without the need for electrical connectors. Impossible? No. We did it. Watch this space for more information.

Noninvasive Glucometer

Currently, 9% of Americans are diabetic; this will rise to 30% of those born in 2000. Diabetes and its complications costs the USA $245 billion/yr in healthcare; pain and suffering cost more.

To make matters worse, only 61% of Type I and 5% of Type II insulin-using diabetics monitor their blood sugar even once/day. Moreover, 75% of hypoglycemic incidents occur at night; the lifetime risk that this ends in death is 6%.

In an effort to address the situation, continuous glucose meters are growing in popularity, but they are cumbersome, uncomfortable, and expensive. There have been efforts to develop other methods for monitoring blood sugar, including a rumored iWatch, tattooing with glucose-sensitive materials, contact lenses that detect glucose in tears, and even photoacoustic spectroscopy, but none are currently in use.

Inovatzia has come up with another approach: re-purpose and re-structure what is already in use to create a radical and disruptive technology that fits you—and monitors blood sugar without breaking the skin. Watch this space for more information about our patent pending Glucotech device.



Dr. Caroline Crocker, CEO

Caroline Crocker, MSc, PhD is an immunopharmacologist with over 15 years of medical research experience, the author of numerous peer-reviewed articles, two books, and over 200 other papers, and has a track record for writing and securing grants. Dr. Crocker is an established and popular speaker, is a proven initiator with experience starting and running a for-profit company, two nonprofit organizations and several other organizations, and is skilled in interacting with investors and the public. Her chief role at Inovatzia is to make it happen—something that she has the experience to do.



Dr. Alexander Reyzelman, CMO

Alexander Reyzelman, DPM, the Chief Medical Officer, is an Associate Professor of the Department of Medicine at the California School of Podiatric Medicine at Samuel Merritt University, is the Co-Director of UCSF Center for Limb Preservation, the President of the Center for Clinical Research Inc., a clinical site management organization, and is an author on numerous peer-reviewed papers. As a recognized leader in diabetic wound care, vascular surgery, and research, Dr. Reyzelman brings invaluable medical expertise to the team.



Stan C. Petrov, Inventor

Stan Petrov is a prolific inventor who has distinguished himself by his abilities in electronics, mechanics, research, and medicine, and an entrepreneur, who started several successful European companies. Stan moved to the USA at 20, not knowing English and without support. Only twelve years later, Stan is an American citizen, has gained a degree in biology, completed his third year of medical school, has submitted several articles to professional peer-reviewed journals, acted as a consultant to a biomedical device company, has been approached by another company wanting to develop and use one of his inventions, did research in neurophysics, and has taught biomechanical and surgical techniques to physicians and professors. At the beginning of his third year in medical school, Stan started a company to develop and market his first major medical invention (Inteli, Corp.), but when the stream of inventions continued to flow, in June of 2013 it became necessary to also start Inovatzia, Inc. as a research company where core technology is housed and the related inventions are developed and marketed.


Work With Us

Inovatzia, Inc. is committed to educating and training others to share in the continuous development and design of innovative and radical hardware, operating systems, application software, peripherals and services that are core to our business philosophy.

If you would like to be considered for a position working with the Inovatzia, Inc. team, just send us an email.

“Working with Inovatzia has been a highly, highly, highly edifying experience.”

“I have benefited greatly from Stan’s unprecedented and unmatched leadership, which is both inspiring and empowering.”


Management Advisory Board

F. Henry Habicht II, Currently Managing Partner, Sail Capital Partners, Irvine, CA. Formerly Assistant Attorney General at the US Department of Justice, COO at the Environmental Protection Agency, Senior VP at Safety Kleen, and CEO and Vice Chairman (current) of the Global Environment and Technology Foundation.

Walter Myers III, Currently Principal Consultant at Microsoft, Orange County, CA. Formerly Senior Software Developer at Harbinger EDI and Director of Finance and Finance Systems at Automobile Protection Corporation.

Gordon Pennington III, Managing Director, Burning Media Group, Formerly Consultant to Apple, Chase Manhattan Bank and J.P. Morgan Bank, Former Director of Marketing for Tommy Hilfiger.


Another Day: Another Patent Application

08/08/2014 4:06 PM

Inovatzia submits a patent application for a novel way to measure glucose in diabetics--without breaking the skin! More information coming soon.



The Inventions Continue

08/04/2014 11:58 AM

Soon you'll want to replace all of these, because the Matrix is coming!



Second Cryo Patent Submitted

07/24/2014 11:56 AM

Development of the Cryo continues--and another patent is needed.



Inovatzia Management Advisory Board Meeting

06/19/2014 7:09 PM

Stan Petrov, Caroline Crocker Alex Reyzelman, Hank and Wendy Habicht, Gordon Pennington, and Alex and Pam Metherell enjoying dinner and discussion.



The Inovatzia Founders Meet with Russell Jaffe, MD, PhD

06/09/2014 7:11 PM

From left to right, Caroline Crocker, Stan Petrov, Russell Jaffe, and Alex Reyzelman enjoying brainstorming while relaxing at Pelican Hill.



Meeting in San Francisco

04/30/2014 4:11 PM

Dr. Reyzelman and Dr. Crocker discuss the potential benefits of the Cryo.



Brainstorming with Advisor

04/26/2014 3:06 PM

CTO Stan Petrov working with Software Engineering Intern Brad English and Management Advisory Team member Walter Myers III.



Perfecting an Invention

04/24/2014 1:58 PM

Stan and intern Brad English at work.



Meador Joins Us

04/22/2014 2:31 PM

Karen Meador, MD, MBA joins the Inovatzia Management Advisory Board. As a physician/pediatrician, consultant, entrepreneurial health care executive and investor with experience in business development and operations management, Dr. Meador provides us with a wealth of important counsel and guidance.



Habicht Joins Us

04/01/2014 4:22 PM

Hank Habicht II joins the Inovatzia Advisory Board. As a managing partner at an investment firm, an established leader, and former CEO and founder of several corporations, Hank provides essential guidance and advice as Inovatzia navigates growing from a start-up to a successful research corporation.



Myers Joins Us

03/10/2014 4:17 PM

Walter Myers III agrees to join the Inovatzia Advisory Board. As a Head Consultant for Microsoft and a software developer, Walter brings us helpful insights into successful business practice and teamwork.



Pennington Joins Us

03/10/2014 3:37 PM

Gordon Pennington III agrees to join the Inovatzia Advisory Board. It is anticipated that Gordon will provide Inovatzia with invaluable information from his wealth of knowledge gained by working in the stock market, as a consultant for Apple and several banks, as a director of marketing for Tommy Hilfiger, as the director of Burning Media Group, and more.



The "M"

02/28/2014 4:09 PM

The patent application for the Medical Adaptable Controller is filed.



Motherboard

12/09/2013 4:01 PM

The patent application for the Wireless and Connection-free Motherboard is filed.



Intelligent Container

12/03/2013 3:57 PM

The patent application for the UV IQ and Derm IQ is filed.



A Week of Meetings

10/29/2013 3:22 PM

Inovatzia has a week of meetings with Gordon Pennington III of Burning Media Group and his associate, Nicholas Lyttle.



Cryogenic Case

09/09/2013 3:44 PM

The patent application for the Cryo is filed.



Inovatzia Moves In

08/05/2013 3:27 PM

Within months of incorporation, Inovatzia took up residence in its new offices in Irvine, CA.



Incorporation

06/12/2013 3:41 PM

Inovatzia is incorporated in California.


Contact Info

Corporate Offices:
18101 Von Karman Ave, 3rd floor
Irvine, CA 92612
Laboratory: Undisclosed location
phone: 949-225-4442

Write Us

Contact form submitted! I'll be in touch soon.




Privacy Policy

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Praesent vestibulum molestie lacus. Aenean nonummy hendrerit mauris. Phasellus porta. Fusce suscipit varius mi. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Nulla dui. Fusce feugiat malesuada odio. Morbi nunc odio, gravida at, cursus nec, luctus a, lorem. Maecenas tristique orci ac sem. Duis ultricies pharetra magna. Donec accumsan malesuada orci. Donec sit amet eros. Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Mauris fermentum dictum magna. Sed laoreet aliquam leo. Ut tellus dolor, dapibus eget, elementum vel, cursus eleifend, elit. Aenean auctor wisi et urna. Aliquam erat volutpat.

Quisque nulla. Vestibulum libero nisl, porta vel, scelerisque eget, malesuada at, neque. Vivamus eget nibh. Etiam cursus leo vel metus. Nulla facilisi. Aenean nec eros. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia Curae; Suspendisse sollicitudin velit sed leo. Ut pharetra augue nec augue. Nam elit magna, hendrerit sit amet, tincidunt ac, viverra sed, nulla. Donec porta diam eu massa. Quisque diam lorem, interdum vitae, dapibus ac, scelerisque vitae, pede. Donec eget tellus non erat lacinia fermentum. Donec in velit vel ipsum auctor pulvinar. Proin ullamcorper urna et felis.

Vestibulum iaculis lacinia est. Proin dictum elementum velit. Fusce euismod consequat ante. Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Pellentesque sed dolor. Aliquam congue fermentum nisl. Mauris accumsan nulla vel diam. Sed in lacus ut enim adipiscing aliquet. Nulla venenatis. In pede mi, aliquet sit amet, euismod in, auctor ut, ligula. Aliquam dapibus tincidunt metus. Praesent justo dolor, lobortis quis, lobortis dignissim, pulvinar ac, lorem. Vestibulum sed ante. Donec sagittis euismod purus.

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt ut labore et dolore.

E-mail: info@demolink.org

Lorem ipsum

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Praesent vestibulum molestie lacus. Aenean nonummy hendrerit mauris. Phasellus porta. Fusce suscipit varius mi. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Nulla dui. Fusce feugiat malesuada odio. Morbi nunc odio, gravida at, cursus nec, luctus a, lorem. Maecenas tristique orci ac sem. Duis ultricies pharetra magna. Donec accumsan malesuada orci. Donec sit amet eros. Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Mauris fermentum dictum magna. Sed laoreet aliquam leo. Ut tellus dolor, dapibus eget, elementum vel, cursus eleifend, elit. Aenean auctor wisi et urna. Aliquam erat volutpat.

Quisque nulla. Vestibulum libero nisl, porta vel, scelerisque eget, malesuada at, neque. Vivamus eget nibh. Etiam cursus leo vel metus. Nulla facilisi. Aenean nec eros. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia Curae; Suspendisse sollicitudin velit sed leo. Ut pharetra augue nec augue. Nam elit magna, hendrerit sit amet, tincidunt ac, viverra sed, nulla. Donec porta diam eu massa. Quisque diam lorem, interdum vitae, dapibus ac, scelerisque vitae, pede. Donec eget tellus non erat lacinia fermentum. Donec in velit vel ipsum auctor pulvinar. Proin ullamcorper urna et felis.

Vestibulum iaculis lacinia est. Proin dictum elementum velit. Fusce euismod consequat ante. Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Pellentesque sed dolor. Aliquam congue fermentum nisl. Mauris accumsan nulla vel diam. Sed in lacus ut enim adipiscing aliquet. Nulla venenatis. In pede mi, aliquet sit amet, euismod in, auctor ut, ligula. Aliquam dapibus tincidunt metus. Praesent justo dolor, lobortis quis, lobortis dignissim, pulvinar ac, lorem. Vestibulum sed ante. Donec sagittis euismod purus.

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt ut labore et dolore.